San Antonio Breast Cancer Symposium presentations underscore safety of assisted reproductive technology and pregnancy in women during and after breast cancer treatment
Analysis suggests association between prior PARP inhibition and subsequent decreased progression-free survival in platinum-sensitive ovarian cancer
Other reproductive and hormonal factors found protective
Will hormone replacement therapy increase breast cancer risk?
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Developing and delivering the care most needed by patients, now
Immunotherapy, PARP inhibitors and a targeted therapy